1,822
Views
11
CrossRef citations to date
0
Altmetric
Research Papers

Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study

, , , &
Pages 1900-1905 | Received 16 Nov 2015, Accepted 14 Jan 2016, Published online: 18 Mar 2016

References

  • Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67:71e79; http://dx.doi.org/10.1136/thx.2009.129502
  • Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 24:1618-24; http://dx.doi.org/10.1056/NEJM199512143332408
  • Marrie TJ. Community-acquired pneumonia in the elderly. Clin Infect Dis 2000; 31:1066-78; PMID:11049791; http://dx.doi.org/10.1086/318124
  • Feldman C. Pneumonia in the elderly. Clin Chest Med 1999; 3:563-73; http://dx.doi.org/10.1016/S0272-5231(05)70236-7
  • Gil-Prieto R, García-García L, Álvaro-Meca A, Méndez C, García A, de Miguel AG. The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003–2007). Vaccine 2011; 29:412-6; PMID:21111780; http://dx.doi.org/10.1016/j.vaccine.2010.11.025
  • Fry AM, Shay DK, Holman RC, Curns AT, Anderson LJ. Trends in hospitalisation s for pneumonia among persons aged 65 years or older in the United States, 1988–2002. JAMA 2005; 294(21):2712-9; PMID:16333006; http://dx.doi.org/10.1001/jama.294.21.2712
  • Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL, AGEDD Adult Pneumococcal Burden Study Team, Andreo F, Beovic B, Blanco S, Boersma WG, et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One 2013; 8(4):e60273. Epub 2013 Apr 2; PMID:23565216; http://dx.doi.org/10.1371/journal.pone.0060273
  • Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, Pilishvili T. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2015; 64(34):944-7. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6434a4.htm last consulted October 27th 2015.
  • Gil-Prieto R, San Martín M, de Andrés AL, Alvaro-Meca A, González A, de Miguel AG. Hospital-acquired rotavirus infections in Spain over a ten-year period (1998–2007). HumVaccin 2009; 5(11):748-53.
  • Gil-Prieto R, García-García L, Alvaro-Meca A, González-Escalada A, Viguera Ester P, Gil De Miguel A. The burden of hospitalizations for meningococcal infection in Spain (1997–2008).Vaccine 2011; 29(34):5765-70; PMID:21664402; http://dx.doi.org/10.1016/j.vaccine.2011.05.089
  • Gil Prieto R, San Román Montero J, Gómez Alejandre C, Alvaro Meca LA, Rivero A, Gil de Miguel A. Epidemiology of pneumococcal meningitis hospitalisations in pediatric population in Spain (1998–2006). Vaccine 2009; 27(20):2669-73; PMID:19428877; http://dx.doi.org/10.1016/j.vaccine.2009.02.063
  • Gil A, San-Martín M, Carrasco P, González A. Epidemiology of pneumonia hospitalisations in Spain, 1995–1998. J Infect 2002; 44(2):84-7.; PMID:12076066; http://dx.doi.org/10.1053/jinf.2002.0966
  • van Hoek AJ, Andrews N, Waight PA, Stowe J, Gates P, George R, Miller E The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect 2012 Jul; 65(1):17-24. http://dx.doi.org/10.1016/j.jinf.2012.02.017. Epub 2012 Mar 3
  • Shea KM, Edelsberg J, Weycker D, Farkouh RA, Strutton DR, Pelton SI. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis 2014 May 27; 1(1):ofu024.
  • Peiro S, Librero J. Evaluación de la calidad a partir del conjunto mínimo de datosbásicos al alta hospitalaria. RevNeurol 1999; 29:651-61.
  • Guevara RE, Butler JC, Marston BJ, Plouffe JF, File Jr TM, Breiman RF. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 1999; 149(3):282-9; PMID:9927225; http://dx.doi.org/10.1093/oxfordjournals.aje.a009804
  • Punarola A. Microbiologia y Parasitologia Medica (Spanish). Elsevier España; 1987.p.354-355, ISBN 84-458-0060-4.
  • Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, van Werkhoven CH, van Deursen AM, Sanders EA, Verheij TJ et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015 Mar 19; 372(12):1114-25.
  • Sociedad Española de Medicina Preventiva, Salud Pública e Higiene. VOL. XX N 2-3-4 2014 ESPECIAL CONSENSO DE VACUNAS. Available at URL: http://sempsph.com/images/stories/recursos/pdf/Consenso%20sobre%20Vacunas%202014/cap%C3%ADtulos%201%20a%2010.pdf last consulted 27/10/2015
  • Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. US hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369:155-63; PMID:23841730; http://dx.doi.org/10.1056/NEJMoa1209165
  • Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32-41; PMID:19947881; http://dx.doi.org/10.1086/648593
  • Rozenbaum MH, van Hoek AJ, Fleming D, Trotter CL, Miller E, Edmunds WJ. Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. BMJ 2012 Oct 26; 345:e6879; http://dx.doi.org/10.1136/bmj.e6879
  • Ministerio de Sanidad, Servicios sociales e Igualdad. Sistema de información sanitaria. registro de actividad de atención especializada. RAE-CMBD Available at http://www.msssi.gob.es/estadEstudios/estadisticas/cmbdhome.htm last consulted 27/10/2015.
  • Ministerio de Sanidad y Consumo. Análisis y desarrollo de los GDR en el Sistema Nacional de Salud. Agustín Rivero. Available at URL: http://www.msssi.gob.es/estadEstudios/estadisticas/docs/analisis.pdf last consulted 27/10/2015 last consulted 27/10/2015.
  • Schreyögg J, Stargardt T, Tiemann O, Busse R. Methods to determine reimbursement rates for diagnosis related groups (DRG): A comparison of nine European countries. Health Care Manag Sci 2006; 9(3):215-23; PMID:17016927; http://dx.doi.org/10.1007/s10729-006-9040-1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.